Imagine being able to know ahead of time when a baby will get a serious infection and then being able to treat the infection before it can affect his or her tender life.
An approved drug for fighting obesity is helping scientists at Wake Forest University School of Medicine uncover clues about how to stop the growth of cancerous tumors.
Medical providers facing a crisis in HIV care are forming a coalition that will stand up for the needs of community health centers, university and hospital clinics, city and county health departments, private clinics, and others providing medical care for low-income people with HIV with nowhere else to turn.
Radiotherapy after breast conserving surgery for breast cancer reduces recurrence and prevents development of additional breast tumors in older women with early stage breast disease, according to a new study.
Radiation therapy after lumpectomy and five years of treatment with the drug tamoxifen can dramatically reduce the risk of both cancer recurrence and new tumors in older women with early breast cancer.
There is near-universal agreement about the need for clinical researchers to disclose financial interests to research participants, but until now there has been little guidance available on exactly how to do it. Using an empirically-based approach, team creates new tool to do the right thing.
Cardiologists at Wake Forest University Baptist Medical Center are helping to lead a large international study involving 83 other sites that will test 3,000 patients in an effort to determine whether exercise really is good for heart failure patients.
A collaborative study conducted by Wake Forest University Baptist Medical Centre and the University of Heidelberg researchers, has lead to the identification of a gene which protects some diabetics from developing severe kidney failure or ?end-stage renal disease?.
Researchers at Wake Forest University School of Medicine are the first to report that in animal studies, a common diabetes drug prevents the memory and learning problems that cancer patients often experience after whole-brain radiation treatments.
A research team at Wake Forest University Baptist Medical Center and the University of Heidelberg has proven that a gene protects some people with diabetes from developing severe kidney failure or “end-stage renal disease.”